T. Rowe Price Associates
GMAB icon

T. Rowe Price Associates’s Genmab GMAB Stock Holding History

T. Rowe Price Associates’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-189,491
Closed -$6.03M – 2965
2023
Q4 		$6.03M Sell
189,491
-11,227
-6% -$353K ﹤0.01% 1170
2023
Q3 		$7.08M Sell
200,718
-50,380
-20% -$1.92M ﹤0.01% 1125
2023
Q2 		$9.54M Hold
251,098
– – ﹤0.01% 1084
2023
Q1 		$9.48M Hold
251,098
– – ﹤0.01% 1070
2022
Q4 		$10.6M Sell
251,098
-1,100
-0.4% -$45.3K ﹤0.01% 1038
2022
Q3 		$8.1M Hold
252,198
– – ﹤0.01% 1101
2022
Q2 		$8.19M Sell
252,198
-1,235,837
-83% -$40M ﹤0.01% 1350
2022
Q1 		$53.8M Sell
1,488,035
-214,996
-13% -$7.38M 0.01% 945
2021
Q4 		$67.4M Sell
1,703,031
-106,547
-6% -$4.44M 0.01% 895
2021
Q3 		$79.1M Sell
1,809,578
-182,863
-9% -$8.21M 0.01% 844
2021
Q2 		$81.4M Buy
1,992,441
+39,357
+2% +$1.52M 0.01% 865
2021
Q1 		$64.1M Buy
1,953,084
+1,536,846
+369% +$57.8M 0.01% 913
2020
Q4 		$16.9M Buy
416,238
+263,788
+173% +$9.86M ﹤0.01% 1257
2020
Q3 		$5.58M Buy
+152,450
New +$5.51M ﹤0.01% 1391
2019
Q4 		– Sell
-21,613
Closed -$438K – 2536
2019
Q3 		$438K Buy
+21,613
New +$426K ﹤0.01% 2147

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $10.6B AUM 19.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates's GMAB Position: Q1 2024 in Review

T. Rowe Price Associates sold out of Genmab (GMAB) in Q1 2024, closing a stake of 189,491 shares — an estimated $6.03M sold.

T. Rowe Price Associates first reported a position in GMAB in Q3 2019 and held it in 15 quarters. The position peaked at $81.4M in Q2 2021. 228 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.

  • T. Rowe Price Associates reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
  • T. Rowe Price Associates sold 189,491 Genmab shares in Q1 2024, an estimated $6.03M.
  • T. Rowe Price Associates first reported a position in Genmab in Q3 2019 and held it in 15 quarters.
  • T. Rowe Price Associates's Genmab position peaked at $81.4M in Q2 2021.
  • 228 funds tracked by Wall St. Rank held Genmab as of Q1 2024.

Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.